Middle Tennessee's robust oncology programs are tackling cancer on numerous fronts.
From personalized medicine to innovation in GI care, Middle Tennessee oncology leaders share promising news.
Oncologist Meredith McKean, MD, MPH, overseeing Sarah Cannon's Melanoma Research Program
Nashville physician-scientists are helping lead the way in advancing cancer care.
On Nov. 13, the Nashville Health Care Council hosted a panel discussion on collaborations between the pharmaceutical and healthcare provider sectors and how those collaborations can drive change in healthcare.
Dax Kurbegov, MD, is joining Sarah Cannon as vice president and physician-in-chief of Clinical Programs where he will oversee expansion and foster collaboration across Sarah Cannon's cancer network.
Genetics playing a significant role in the future of lung cancer treatment.
It's a diagnosis everyone fears, but Tennessee Oncology and Sarah Cannon physician-scientist Erika P. Hamilton, MD said advances in clinical care and research are helping turn the tide on cancer.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: